Physician profile
John W Odom
NPI 1508866773
$40,236.41
in general payments reported to CMS, 2019-2025
11 companies · $88.70 in 2025
The $88.70 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,848 · 2020: $5,210 · 2021: $16K · 2022: $8,902 · 2023: $5,473 · 2024: $61.79 · 2025: $88.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,075 · Travel and Lodging: $316 · Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,075.00 |
| Travel and Lodging | $315.72 |
| Food and Beverage | $232.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $29,976.52 | 2021-2024 | Permacol, Progrip |
| Covidien LP | $9,781.73 | 2019-2020 | |
| Allergan, INC. | $136.87 | 2019-2020 | |
| Medtronic USA, INC. | $123.67 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $54.17 | 2022-2023 | |
| Smith+Nephew, INC. | $46.63 | 2025 | Grafix Pl, Stravix |
| Enterra Medical, INC. | $42.07 | 2025 | |
| Baxter Healthcare | $22.63 | 2022 | |
| Organogenesis INC. | $21.68 | 2022 | |
| Shire North American Group INC | $15.56 | 2019 | |
| Innocoll Pharmaceuticals Limited | $14.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Odom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.